Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.

Streptococcus agalactiae (group B Streptococcus; GBS) remains a dominant cause of serious neonatal infections. One aspect of GBS that renders it particularly virulent during the perinatal period is its ability to invade the chorioamniotic membranes and persist in amniotic fluid, which is nutritional...

Full description

Bibliographic Details
Main Authors: Allison N Dammann, Anna B Chamby, Andrew J Catomeris, Kyle M Davidson, Hervé Tettelin, Jan-Peter van Pijkeren, Kathyayini P Gopalakrishna, Mary F Keith, Jordan L Elder, Adam J Ratner, Thomas A Hooven
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-03-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1009116
_version_ 1818548776894201856
author Allison N Dammann
Anna B Chamby
Andrew J Catomeris
Kyle M Davidson
Hervé Tettelin
Jan-Peter van Pijkeren
Kathyayini P Gopalakrishna
Mary F Keith
Jordan L Elder
Adam J Ratner
Thomas A Hooven
author_facet Allison N Dammann
Anna B Chamby
Andrew J Catomeris
Kyle M Davidson
Hervé Tettelin
Jan-Peter van Pijkeren
Kathyayini P Gopalakrishna
Mary F Keith
Jordan L Elder
Adam J Ratner
Thomas A Hooven
author_sort Allison N Dammann
collection DOAJ
description Streptococcus agalactiae (group B Streptococcus; GBS) remains a dominant cause of serious neonatal infections. One aspect of GBS that renders it particularly virulent during the perinatal period is its ability to invade the chorioamniotic membranes and persist in amniotic fluid, which is nutritionally deplete and rich in fetal immunologic factors such as antimicrobial peptides. We used next-generation sequencing of transposon-genome junctions (Tn-seq) to identify five GBS genes that promote survival in the presence of human amniotic fluid. We confirmed our Tn-seq findings using a novel CRISPR inhibition (CRISPRi) gene expression knockdown system. This analysis showed that one gene, which encodes a GntR-class transcription factor that we named MrvR, conferred a significant fitness benefit to GBS in amniotic fluid. We generated an isogenic targeted deletion of the mrvR gene, which had a growth defect in amniotic fluid relative to the wild type parent strain. The mrvR deletion strain also showed a significant biofilm defect in vitro. Subsequent in vivo studies showed that while the mutant was able to cause persistent murine vaginal colonization, pregnant mice colonized with the mrvR deletion strain did not develop preterm labor despite consistent GBS invasion of the uterus and the fetoplacental units. In contrast, pregnant mice colonized with wild type GBS consistently deliver prematurely. In a sepsis model the mrvR deletion strain showed significantly decreased lethality. In order to better understand the mechanism by which this newly identified transcription factor controls GBS virulence, we performed RNA-seq on wild type and mrvR deletion GBS strains, which revealed that the transcription factor affects expression of a wide range of genes across the GBS chromosome. Nucleotide biosynthesis and salvage pathways were highly represented among the set of differentially expressed genes, suggesting that MrvR may be involved in regulating nucleotide availability.
first_indexed 2024-12-12T08:24:41Z
format Article
id doaj.art-3493e7f3e0ba42799bba78ade439f8e2
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-12T08:24:41Z
publishDate 2021-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-3493e7f3e0ba42799bba78ade439f8e22022-12-22T00:31:17ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742021-03-01173e100911610.1371/journal.ppat.1009116Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.Allison N DammannAnna B ChambyAndrew J CatomerisKyle M DavidsonHervé TettelinJan-Peter van PijkerenKathyayini P GopalakrishnaMary F KeithJordan L ElderAdam J RatnerThomas A HoovenStreptococcus agalactiae (group B Streptococcus; GBS) remains a dominant cause of serious neonatal infections. One aspect of GBS that renders it particularly virulent during the perinatal period is its ability to invade the chorioamniotic membranes and persist in amniotic fluid, which is nutritionally deplete and rich in fetal immunologic factors such as antimicrobial peptides. We used next-generation sequencing of transposon-genome junctions (Tn-seq) to identify five GBS genes that promote survival in the presence of human amniotic fluid. We confirmed our Tn-seq findings using a novel CRISPR inhibition (CRISPRi) gene expression knockdown system. This analysis showed that one gene, which encodes a GntR-class transcription factor that we named MrvR, conferred a significant fitness benefit to GBS in amniotic fluid. We generated an isogenic targeted deletion of the mrvR gene, which had a growth defect in amniotic fluid relative to the wild type parent strain. The mrvR deletion strain also showed a significant biofilm defect in vitro. Subsequent in vivo studies showed that while the mutant was able to cause persistent murine vaginal colonization, pregnant mice colonized with the mrvR deletion strain did not develop preterm labor despite consistent GBS invasion of the uterus and the fetoplacental units. In contrast, pregnant mice colonized with wild type GBS consistently deliver prematurely. In a sepsis model the mrvR deletion strain showed significantly decreased lethality. In order to better understand the mechanism by which this newly identified transcription factor controls GBS virulence, we performed RNA-seq on wild type and mrvR deletion GBS strains, which revealed that the transcription factor affects expression of a wide range of genes across the GBS chromosome. Nucleotide biosynthesis and salvage pathways were highly represented among the set of differentially expressed genes, suggesting that MrvR may be involved in regulating nucleotide availability.https://doi.org/10.1371/journal.ppat.1009116
spellingShingle Allison N Dammann
Anna B Chamby
Andrew J Catomeris
Kyle M Davidson
Hervé Tettelin
Jan-Peter van Pijkeren
Kathyayini P Gopalakrishna
Mary F Keith
Jordan L Elder
Adam J Ratner
Thomas A Hooven
Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
PLoS Pathogens
title Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
title_full Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
title_fullStr Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
title_full_unstemmed Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
title_short Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.
title_sort genome wide fitness analysis of group b streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits
url https://doi.org/10.1371/journal.ppat.1009116
work_keys_str_mv AT allisonndammann genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT annabchamby genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT andrewjcatomeris genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT kylemdavidson genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT hervetettelin genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT janpetervanpijkeren genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT kathyayinipgopalakrishna genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT maryfkeith genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT jordanlelder genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT adamjratner genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits
AT thomasahooven genomewidefitnessanalysisofgroupbstreptococcusinhumanamnioticfluidrevealsatranscriptionfactorthatcontrolsmultiplevirulencetraits